Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The human
TATA-binding protein
was expressed in Escherichia coli as a fusion with an N-terminal hexahistidine sequence, partially purified, and used to raise monoclonal antibodies. More than 50 hybridoma clones producing antibodies that reacted in immunoblot assays with HeLa cell
TATA-binding protein
and its bacterially synthesized derivative were identified. All antibodies examined recognized epitopes within the N-terminal 159 amino acids of the human
TATA-binding protein
. Further characterization of one monoclonal antibody,
MTBP
-6, established that it immunoprecipitates both native HeLa cell
TATA-binding protein
and
TATA-binding protein
extracted from cells in the presence of 0.5% SDS. Antibody
MTBP
-6 immunoprecipitates of native, human cell
TATA-binding protein
contained the
TATA-binding protein
and additional polypeptides. Immunoprecipitation of both the
TATA-binding protein
and several additional polypeptides was specifically blocked by bacterially synthesized, hexahistidine-tagged
TATA-binding protein
, suggesting that
MTBP
-6 can efficiently recognize the
TATA-binding protein
in TFIID and other complexes. Consistent with this conclusion, immunoaffinity chromatography on antibody
MTBP
-6 permitted purification, in active form, of a
TATA-binding protein
-containing factor required for transcription by RNA polymerase III. These properties suggest that
MTBP
-6 will be a useful reagent for the purification and characterization of the multiple TBP-containing complexes present in human cells.
...
PMID:Purification of an active TATA-binding protein-containing factor using a monoclonal antibody that recognizes the human TATA-binding protein. 750 37